CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$87.75
−18.38%0
Insider buys (3m)
59
Insider sells (3m)
-$53.9M
Net value (3m)
-2.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 16, 2026 | WILSON JAMES N · director | Sale | 6,654 | $114 |
| Oct 16, 2026 | WILSON JAMES N · director | Sale | 300 | $116 |
| Oct 16, 2026 | WILSON JAMES N · director | Sale | 3,046 | $115 |
| Oct 5, 2026 | Vieira Roberto Wandenkolk · officer: President, Oncology | M-Exempt | 8,333 | $22 |
| Oct 5, 2026 | Lyon Joseph Douglas · officer: See Remarks | Sale | 4,446 | $116 |
| Oct 5, 2026 | Lyon Joseph Douglas · officer: See Remarks | Sale | 4,744 | $117 |
| Oct 5, 2026 | Vieira Roberto Wandenkolk · officer: President, Oncology | Sale | 1,100 | $115 |
| Oct 5, 2026 | Lyon Joseph Douglas · officer: See Remarks | M-Exempt | 810 | $14 |
| Oct 5, 2026 | Vieira Roberto Wandenkolk · officer: President, Oncology | Sale | 2,086 | $116 |
| Oct 5, 2026 | Lyon Joseph Douglas · officer: See Remarks | Sale | 810 | $115 |
| Oct 5, 2026 | Lyon Joseph Douglas · officer: See Remarks | M-Exempt | 5,833 | $19 |
| Oct 5, 2026 | Lyon Joseph Douglas · officer: See Remarks | M-Exempt | 3,357 | $14 |
| Oct 5, 2026 | Maduck Sean · officer: See Remarks | Sale | 413 | $116 |
| Oct 5, 2026 | Maduck Sean · officer: See Remarks | Sale | 8,744 | $117 |
| Oct 5, 2026 | Maduck Sean · officer: See Remarks | M-Exempt | 413 | $8.27 |
| Oct 5, 2026 | Gunn Justin Frederick · officer: See Remarks | A-Award | 100,000 | $114 |
| Oct 5, 2026 | Maduck Sean · officer: See Remarks | M-Exempt | 24,587 | $8.27 |
| Oct 5, 2026 | Maduck Sean · officer: See Remarks | Sale | 15,843 | $116 |
| Oct 5, 2026 | Vieira Roberto Wandenkolk · officer: President, Oncology | Sale | 5,147 | $117 |
| Sep 18, 2026 | Vieira Roberto Wandenkolk · officer: President, Oncology | Sale | 296 | $101 |
| Sep 18, 2026 | Robb Gary Charles · officer: Chief Business Officer | M-Exempt | 17,493 | $8.27 |
| Sep 16, 2026 | WILSON JAMES N · director | Sale | 2,800 | $112 |
| Sep 16, 2026 | WILSON JAMES N · director | Sale | 400 | $111 |
| Sep 16, 2026 | Lyon Joseph Douglas · officer: See Remarks | Sale | 7,812 | $113 |
| Sep 16, 2026 | Lyon Joseph Douglas · officer: See Remarks | M-Exempt | 7,404 | $14 |
| Sep 16, 2026 | Lyon Joseph Douglas · officer: See Remarks | M-Exempt | 2,596 | $11 |
| Sep 16, 2026 | WILSON JAMES N · director | Sale | 6,800 | $110 |
| Sep 16, 2026 | Lyon Joseph Douglas · officer: See Remarks | Sale | 2,188 | $114 |
| Sep 3, 2026 | Vieira Roberto Wandenkolk · officer: President, Oncology | Sale | 23,600 | $109 |
| Sep 3, 2026 | Robb Gary Charles · officer: Chief Business Officer | F-InKind | 91 | $113 |
Institutional positioning
13F filings over the trailing two quarters
New 212Increased 266Reduced 250Sold out 53
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 12,432,023 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 12,151,276 | May 13, 2026 |
| INGALLS & SNYDER LLC | Increased | 7,947,007 | Aug 14, 2026 |
| INGALLS & SNYDER LLC | Increased | 7,611,916 | May 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 5,682,783 | May 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 5,261,628 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 5,044,638 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4,820,568 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,172,482 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,077,196 | May 15, 2026 |
| PARALLEL ADVISORS, LLC | Increased | 3,977,404 | Jun 3, 2026 |
| Parallel Advisors, LLC | Reduced | 3,962,177 | Aug 5, 2026 |
| FMR LLC | Increased | 3,337,618 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 3,279,381 | Sep 22, 2026 |
| STATE STREET CORP | Increased | 3,200,946 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 16, 2026